EUVIMEDEUVIMED entdecken
Open Access

Droplet Digital PCR Measurement of HBV DNA in On‐Treatment Chronic HBV Patients: Association With HCC Development and Outcomes

Rex Wan-Hin Hui iD, Danny Ka-Ho Wong, James Fung iD, Ka-Shing Cheung iD, Wai-Kay Seto iD, Lung-Yi Mak iD, Man-Fung Yuen iD

Journal of Viral Hepatitis · 2026-08 · 33 (8)

DOI: 10.1111/jvh.70209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 13.07.2026. Verfasst von Rex Wan-Hin Hui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, The University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Carcinoma, Hepatocellular, DNA, Viral, Liver Neoplasms. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low‐level residual viremia can be present in chronic hepatitis B (CHB) patients on nucleos(t)ide analogues (NUCs). Due to the detection limits of current HBV DNA assays, the association between residual viremia and HBV‐related HCC has not been well studied. This study included NUC‐treated HBV‐related HCC patients with unquantifiable serum HBV DNA by the conventional Cobas‐Taqman assay (< 20 IU/mL) at HCC diagnosis. The HCC patients were matched in a 1:1 ratio with NUC‐treated non‐HCC controls. Serum samples at the time of HCC diagnosis, 1 year before, and 2 years before diagnosis were retrospectively retrieved and tested for residual viremia by a validated high‐sensitivity droplet digital polymerase chain reaction assay (lower limit of detection 1.6 IU/mL). Among 208 patients (104 HCC vs. 104 controls; mean age 63.1, 80.8% male, 54.3% cirrhosis), residual viremia within 2 years was observed in 82.7% of HCC patients and 49.0% of controls ( p < 0.001), and was independently associated with HCC occurrence (OR 7.243, 95% CI 1.862–28.170, p = 0.004). In HCC patients, residual viremia was associated with histological microvascular invasion (44.4% vs. 9.1% in patients without residual viremia, p = 0.033) and lower probability of presenting with Barcelona Clinic Liver Cancer stage 0 HCC (OR 0.281, 95% CI 0.094–0.838, p = 0.023). After median follow‐up for 7.2 years, residual viremia within 2 years before HCC diagnosis was independently associated with liver‐related mortality (HR 4.472, 95% CI 1.212–16.504, p = 0.025). Residual viremia in NUC‐treated CHB patients is associated with a higher risk of HCC development, more advanced tumour staging and poorer outcomes. High‐sensitivity HBV DNA assays may be utilized for monitoring in NUC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicCarcinoma, HepatocellularDNA, ViralLiver NeoplasmsAntiviral AgentsPolymerase Chain ReactionHepatitis B virusHumansMaleFemaleMiddle AgedRetrospective StudiesViremiaAgedViral LoadTreatment OutcomeAdult

Stichwörter der Autor:innen

DNAHBVHCCantiviralshigh‐sensitivity

Substanzen

DNA, ViralAntiviral Agents

Autor:innen und Institutionen

  • Department of Medicine, The University of Hong Kong, Hong Kong, China.
  • State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China.
  • Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.

ORCID-Profile: Rex Wan-Hin Hui, James Fung, Ka-Shing Cheung, Wai-Kay Seto, Lung-Yi Mak, Man-Fung Yuen

Zitieren

APA

Hui, R. W., Wong, D. K., Fung, J., Cheung, K. S., Seto, W. K., Mak, L. Y., & Yuen, M. F. (2026). Droplet Digital PCR Measurement of HBV DNA in On‐Treatment Chronic HBV Patients: Association With HCC Development and Outcomes. Journal of Viral Hepatitis, 33(8). https://doi.org/10.1111/jvh.70209

Vancouver

Hui RW, Wong DK, Fung J, Cheung KS, Seto WK, Mak LY, et al. Droplet Digital PCR Measurement of HBV DNA in On‐Treatment Chronic HBV Patients: Association With HCC Development and Outcomes. Journal of Viral Hepatitis. 2026;33(8). doi:10.1111/jvh.70209

BibTeX
@article{Hui2026,
  author = {Hui, Rex Wan-Hin and Wong, Danny Ka-Ho and Fung, James and Cheung, Ka-Shing and Seto, Wai-Kay and Mak, Lung-Yi and Yuen, Man-Fung},
  title = {Droplet Digital PCR Measurement of HBV DNA in On‐Treatment Chronic HBV Patients: Association With HCC Development and Outcomes},
  journal = {Journal of Viral Hepatitis},
  year = {2026},
  volume = {33},
  number = {8},
  doi = {10.1111/jvh.70209}
}
Kostenlos starten →